Barry S. Skikne
Director/Board Member at TVAX BIOM
Barry S. Skikne active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TVAX BIOM | Director/Board Member | 2011-11-30 | - |
| Independent Dir/Board Member | 2011-11-30 | - |
Career history of Barry S. Skikne
Former positions of Barry S. Skikne
| Companies | Position | Start | End |
|---|---|---|---|
| University of Kansas | Corporate Officer/Principal | 2007-06-30 | 2007-06-30 |
Training of Barry S. Skikne
| University of the Witwatersrand | Undergraduate Degree |
| University of South Africa | Doctorate Degree |
Statistics
International
| United States | 3 |
| South Africa | 3 |
Operational
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
TVAX Biomedical, Inc.
 TVAX Biomedical, Inc. BiotechnologyHealth Technology TVAX Biomedical, Inc. manufactures and sells healthcare products. It is a biotechnology company, which focuses on the development of targeted cell-based immunotherapies for the treatment of cancer and is performing clinical trials with specific focus on brain cancers. The firm’s proprietary immunologic treatment, TVAX Immunotherapy, uses a patient's cells to create activated, genetically unique cancer-killing T cells that can destroy the patient's cancer cells, including cancer stem cells, which are widely believed to be responsible for cancer growth, spread and metastasis. The company was founded by Gray W. Wood, Frank P. Holladay, Catherine E. Lucasey and Lowell Lynn Tilzer on July 14, 2011 and is headquartered in Lenexa, KS. | Health Technology |
- Stock Market
- Insiders
- Barry S. Skikne
- Experience
